Brain Research
Overviews
Bipolar Spectrum
Causes
Dual Diagnosis
Diagnosis
Criteria
Bipolar Spectrum
Screening Tools
Treatment
Medications
Psychotherapy
Non-Prescription
Exercise
Omega3
Sleep
Drug Info
Medication List
Zyprexa/olanzapine
Lamictal/lamotrigine
Prozac/fluoxetine
Mood
Stabilizers
Antidepressants
Side Effects
Studies-Bipolar
Studies-Other
Drug Searches
Links
SO Support
Transcripts
Interviews
Famous
Bipolars
Misc
Brain Research
Updated Sites
Juvenile Bipolar
Overviews
Diagnosis
Treatment
Medications
Bipolar and ADHD
Psychotherapy
School
Family Experiences
Substance Abuse
Articles
Scales and Charts
Links
Award
Direct link
News and Articles This site keeps up an extensive list of bipolar news and articles.
Hospital find may help bipolar disorder Professor Dean's research has shown that a component of the brain called the GABAa receptor is altered in people who have bipolar disorder
U-M
team finds evidence of brain chemistry abnormalities in bipolar disorder
30% higher concentration of certain signaling cells may help explain, treat
"manic depression
"U-M team finds evidence of brain chemistry abnormalities in bipolar disorder "
Evidence of Brain Abnormalities in Bipolar Disorder Medscape In this study done by University of Michigan researchers, Bipolar patients had about 30% more of the cells that release dopamine, serotonin and norepinephrine
Monoamines explain manic episodes in bipolar disorders same study
Abnormal Brain Chemistry Found in Bipolar Disorder about.com Easy to read write up of the same study. To put it simply, these patients' brains are wired differently, in a way that we might expect to predispose them to bouts of mania and depression," says Jon-Kar Zubieta, M.D., Ph.D., assistant professor of psychiatry and radiology at the University of Michigan Health System
Genetic Research Its Implications for Bipolar Disorder Arline Kaplan
Excess Monoaminergic Synaptic Terminals Associated With Bipolar I Disorder Medscape (Reuters Health) Oct 9,2000 Am J Psychiatry 2000;157:1619-1628 Abnormally high concentrations of the vesicular monoamine transporter protein (VMAT2) — and presumably monoaminergic synaptic terminals — appears to be a trait-related abnormality in patients with bipolar I disorder.
Brain Changes in Depression University of Mississippi Medical Center 4-May-99
Depression and the Birth and Death of Brain Cells
ScienceDaily Magazine -- Sustained Use Of Anti-Depressants Increases Cell Growth And Protects Cells In The Brain Posted 12/15/2000
Discovery of brain phenomenon could lead to better drugs for certain mental illnesses
Eukalert
Glucocorticoids
and Hippocampal Atrophy in Neuropsychiatric Disorders
arch of gen psych
BJP -- McQUADE and YOUNG 177 (5) 390
Future therapeutic targets in mood disorders: the glucocorticoid receptor
Too Many Brain Cells Mean Mood Disorder
GABA-A
Alpha-2 Receptor Subunit Proposed as Target for Antianxiety Drugs medscape
reuters news Science 2000;290:131-134.
ScienceDaily Magazine -- Gene Identified That May Play Role In Psychological Disorders
Human Emotion Processing at the Neuronal Level Investigated medscape
A genetic basis for attachment disorganization in infants
1 November 2000 eurekalert
assoiciated with genetic variations in the dopamine receptor (DRD4) gene.
Corticotropin-Releasing Hormone Receptor-2 Modulates Stress, Anxiety Responses medscape Mar 28 Nature Genetics
New Research May Mean Better Antianxiety Medications about.com
Estrogen deprivation leads to death of dopamine cells in the brain
Brain Abnormalities Common in Survivors of Childhood Abuse medscape Dec.21, 2000 His group found that left-sided EEG abnormalities, rare in nonabused individuals, were more than twice as common as right-sided abnormalities in the abused group
Psychiatric Times
Amino Acid Precursors for Depression
Medical Illness and Depressive Disorders
Unraveling the Riddle of Schizophrenia and Bipolar Disorder
The
Co-occurence
of
Bipolar
Disorder
and Multiple
Sclerosis
Journal of Neurological Sciences 1999 It claims that there is an increased
prevalence of bipolar disorder among MS patients but at 1.54% , the figure
is inline with current occurrence estimates.Corticosteroids
are well-known precipitants of mental disturbances and mood disorder.
Hypomanic episodes induced by corticosteroids generally begin early during
treatment, occur in particular when high doses are administered, and resolve
without additional medication within a couple of days after stopping the
treatment